Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.
In a prospective study of 41 acutely psychotic patients, neuroleptic-induced dystonic reactions occurred in 62.5% of the manic patients (10 of 16) and 66.7% of the schizophrenic patients (10 of 15), a nonsignificant difference. These findings contradict a recent report suggesting a higher risk for this side effect in mania.
Remington
G J
GJ
Clarke Institute of Psychiatry, Toronto, Ont., Canada.
Voineskos
G
G
Pollock
B
B
Reed
K
K
Coulter
K
K
D000208:Acute Disease; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000139:chemically induced* / Q000453:epidemiology; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D012559:Schizophrenia / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy / Q000523:psychology; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D008094:Lithium; D006220:Haloperidol